NCT07336914 Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes
| NCT ID | NCT07336914 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Khyber Medical University Peshawar |
| Condition | Gestational Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-10-01 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study involved two management protocols to manage diabetes in pregnancy. Sixty patients having GDM will be recruited on the basis of the OGTT and randomly allocated to two management groups. One group of patients will receive counselling and the conventional method of management. while the other group will receive a tailored diet plan and physical activity with low caloric and moderate intense exercises. Both groups will receive a dietary plan based on their sugar levels weekly basis and physical activity with pharmacotherapy to adjust their sugar levels, while the intensive group will have rigorous monitoring on a monthly basis and frequent visits with repeated lab checks. This will help us to reduce short and long-term complications with improved maternal and neonatal outcomes.
Eligibility Criteria
Inclusion Criteria: * Maternal age between 18-45 years * Gestational age at enrollment 24 - 28 weeks * Patients having Hba1c levels less then 6% Exclusion Criteria: * Patients having twin pregnancies * Patients having PCOS * Diabetes diagnosed prior to pregnancy * Patients having severe hypertension * Patients having renal diseases * Patients using glucose altering medications
Contact & Investigator
Dr Kausar Tayyab, PhD*
PRINCIPAL INVESTIGATOR
Institute of Basic Medical Sciences, Khyber Medical University
Frequently Asked Questions
Who can join the NCT07336914 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07336914 currently recruiting?
Yes, NCT07336914 is actively recruiting participants. Contact the research team at kausar.tayyab1234@gmail.com for enrollment information.
Where is the NCT07336914 trial being conducted?
This trial is being conducted at Peshawar, Pakistan, Peshawar, Pakistan.
Who is sponsoring the NCT07336914 clinical trial?
NCT07336914 is sponsored by Khyber Medical University Peshawar. The principal investigator is Dr Kausar Tayyab, PhD* at Institute of Basic Medical Sciences, Khyber Medical University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.